{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:15:04Z","timestamp":1770430504908,"version":"3.49.0"},"reference-count":119,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecological Endocrinology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1080\/09513590500128492","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T19:32:01Z","timestamp":1126035121000},"page":"343-360","source":"Crossref","is-referenced-by-count":35,"title":["Breast cancer and sex steroids: Critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer"],"prefix":"10.1080","volume":"20","author":[{"given":"Angiolo","family":"Gadducci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Biglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Sismondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Riccardo","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.11.892"},{"key":"CIT0002","first-page":"477","volume":"86","author":"Yue W","year":"2003","journal-title":"Cavalieri EL. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcino-genesis. J Steroid Biochem Mol Biol"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","author":"Key TJ","year":"1988","journal-title":"Eur J Cancer Chin Oncol"},{"key":"CIT0005","first-page":"72","volume":"72","author":"Gunson DE","year":"1995","journal-title":"Prevention of sponta-neous tumors in female rats by fadrozole hydrochloride, an aromatase inhibitor. Br J Cancer"},{"key":"CIT0006","first-page":"606","volume":"94","author":"Key T","year":"2002","journal-title":"Endo-genous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/09513599909167590","volume":"13","author":"Gadducci A","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"CIT0008","first-page":"1031","volume":"5","author":"Gadducci A","year":"2004","journal-title":"Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body. Curr Opin Investig Drugs"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ajcp\/88.2.132","volume":"88","author":"Jones B","year":"1987","journal-title":"Am J Chin Pathol"},{"key":"CIT0011","first-page":"49","volume":"28","author":"Wasserman L","year":"2004","journal-title":"Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors. Int J Obes Relat Metab Disord"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.breast.2003.03.001","volume":"13","author":"Carmichael AR","year":"2004","journal-title":"Breast"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00001648-199503000-00009","volume":"6","author":"Ursin G","year":"1995","journal-title":"Epidemiology"},{"key":"CIT0014","first-page":"164","volume":"24","author":"Helewa M","year":"2002","journal-title":"Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","volume":"360","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2002","journal-title":"Lancet"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"15578","DOI":"10.1073\/pnas.192561299","volume":"99","author":"Forster C","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"CIT0018","first-page":"3007","volume":"87","author":"Santen RJ","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"CIT0019","first-page":"40","volume":"21","author":"Liehr JG","year":"2000","journal-title":"Endocr Rev"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.pa.36.040196.001223","volume":"36","author":"Yager JD","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CIT0021","first-page":"75","volume":"27","author":"Cavalieri E","year":"2000","journal-title":"Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J Natl Cancer Inst Monogr"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"Evan GI","year":"2001","journal-title":"Nature"},{"key":"CIT0023","first-page":"371","volume":"18","author":"Gadducci A","year":"1997","journal-title":"Eur J Gynaecol Oncol"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1521-690X(03)00045-9","volume":"18","author":"Helle SI","year":"2004","journal-title":"Best Pract Res Chin Endocrinol Metab"},{"key":"CIT0027","first-page":"1393","volume":"351","author":"Hankinson SE","year":"1998","journal-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet"},{"key":"CIT0028","first-page":"418","volume":"111","author":"Shi R","year":"2004","journal-title":"hit J Cancer"},{"key":"CIT0029","first-page":"286","volume":"23","author":"Gao J","year":"2003","journal-title":"Effect of estrogen on telomerase activity in human breast cancer cells. J Huazhong Univ Sci Technolog Med Sci"},{"key":"CIT0031","first-page":"39","volume":"9","author":"Takei H","year":"2002","journal-title":"In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer. Breast Cancer"},{"key":"CIT0032","first-page":"1858","volume":"46","author":"Li JJ","year":"1987","journal-title":"Fed Proc"},{"key":"CIT0033","first-page":"235","volume":"60","author":"Newbold RR","year":"2000","journal-title":"Cancer Res"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jbt.20005","volume":"18","author":"Patel MM","year":"2004","journal-title":"J Biochem Mol Toxicol"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(90)90108-U"},{"key":"CIT0037","first-page":"166","volume":"40","author":"Terashima I","year":"2001","journal-title":"Mutagenic properties of estrogen-quinone derived DNA adducts in Simian kidney cells. Biochemistry"},{"key":"CIT0040","first-page":"6716","volume":"61","author":"Dawling S","year":"2001","journal-title":"Catechol-O-methyltransferase (COMT)-mediated metabo-lism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res"},{"key":"CIT0042","first-page":"4870","volume":"59","author":"Huang CS","year":"1999","journal-title":"Cancer Res"},{"key":"CIT0044","first-page":"8492","volume":"63","author":"Hachey DL","year":"2003","journal-title":"Cancer Res"},{"key":"CIT0045","first-page":"150","volume":"54","author":"Tsao AS","year":"2004","journal-title":"Chemoprevention of cancer. CA Cancer J Chin"},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"Fisher B","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"CIT0047","first-page":"98","volume":"352","author":"Powles T","year":"1998","journal-title":"Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet"},{"key":"CIT0048","first-page":"93","volume":"352","author":"Veronesi U","year":"1998","journal-title":"Italian Tamoxifen Prevention Study. Lancet"},{"key":"CIT0049","first-page":"1122","volume":"359","author":"Veronesi U","year":"2002","journal-title":"Tamoxifen for breast cancer among hysterectomised women. Lancet"},{"key":"CIT0050","first-page":"817","volume":"360","author":"Cuzick J","year":"2002","journal-title":"First results from the International Breast Cancer Interven-tion Study (IBIS-I): a randomised prevention trial. Lancet"},{"key":"CIT0051","first-page":"2189","volume":"281","author":"Cummings SR","year":"1999","journal-title":"Multiple Outcomes of Raloxifene Evaluation. J Am Med Assoc"},{"key":"CIT0052","first-page":"1142","volume":"83","author":"Buzdar AU","year":"1998","journal-title":"Lee D. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group. Cancer"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.21.1847"},{"key":"CIT0054","first-page":"245","volume":"36","author":"Jordan VC","year":"1984","journal-title":"Pharmacol Rev"},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","volume":"20","author":"Grann VR","year":"2002","journal-title":"J Chin Oncol"},{"key":"CIT0058","first-page":"216","volume":"287","author":"Cummings SR","year":"2002","journal-title":"Serum estradiol level and risk of breast cancer during treatment with raloxifene. J Am Med Assoc"},{"issue":"96","key":"CIT0059","first-page":"1751\u2013","volume":"2004","author":"Martino S","year":"1761","journal-title":"J Natl Cancer Inst"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1040-8428(03)00157-4","volume":"49","author":"Serrano D","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01685-X"},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jnci\/94.4.274","volume":"94","author":"O'Regan RM","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"CIT0063","first-page":"2047","volume":"88","author":"Gradishar W","year":"2000","journal-title":"Effects of high dose raloxifene in selected patients with advanced breast carcinoma. Cancer"},{"key":"CIT0064","first-page":"296","volume":"361","author":"Cuzick J","year":"2003","journal-title":"Overview of the main outcomes in breast-cancer prevention trials. Lancet"},{"key":"CIT0065","first-page":"1451","volume":"351","author":"Early Breast Cancer Trialists","year":"1998","journal-title":"Tamox-ifen for early breast cancer: an overview of the randomised trials. Lancet"},{"key":"CIT0066","first-page":"2633","volume":"17","author":"Decensi A","year":"1999","journal-title":"Effect of blood tamoxifen concentra-tions on surrogate biomarkers in a trial of dose reduction in healthy women. J Chin Oncol"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.11.779"},{"key":"CIT0068","first-page":"671","volume":"7","author":"Chang J","year":"1996","journal-title":"The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Ann Oncol"},{"key":"CIT0069","first-page":"113","volume":"949","author":"Guerrieri-Gonzaga A","year":"2001","journal-title":"A. The Italian breast cancer prevention trial with tamoxifen: findings and new perspectives. Ann NY Acad Sci"},{"key":"CIT0070","first-page":"453","volume":"16","author":"Dombernowsky P","year":"1998","journal-title":"J Chin Oncol"},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1200\/JCO.2000.18.7.1399","volume":"18","author":"Kaufmann M","year":"2000","journal-title":"The Exemestane Study Group. J Clin Oncol"},{"key":"CIT0073","first-page":"3758","volume":"18","author":"Nabholtz JM","year":"2000","journal-title":"von Euler M. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. J Chin Oncol"},{"key":"CIT0075","first-page":"2247","volume":"92","author":"Bonneterre J","year":"2001","journal-title":"Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer"},{"key":"CIT0076","first-page":"2596","volume":"19","author":"Mouridsen H","year":"2001","journal-title":"Superior efficacy of letrozole versus tamoxifen as first-line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol"},{"key":"CIT0077","first-page":"1391","volume":"14","author":"Paridaens R","year":"2003","journal-title":"Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Ann Oncol"},{"key":"CIT0078","first-page":"2131","volume":"359","author":"Baum M","year":"2002","journal-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet"},{"issue":"98","key":"CIT0079","first-page":"1802\u2013","volume":"2003","author":"Baum M","year":"1810","journal-title":"Cancer"},{"key":"CIT0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0960-0760(03)00378-9","volume":"86","author":"Goss PE","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"CIT0081","first-page":"127","volume":"15","author":"Marchetti P","year":"2004","journal-title":"Ann Oncol"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.22.1655"},{"key":"CIT0083","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/bjc.1998.358","volume":"77","author":"Favoni RE","year":"1998","journal-title":"Br J Cancer"},{"key":"CIT0084","first-page":"4722","volume":"9","author":"Decensi A","year":"2003","journal-title":"Clin Cancer Res"},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"key":"CIT0086","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","volume":"346","author":"Marchbanks PA","year":"2002","journal-title":"N Engl J Med"},{"key":"CIT0087","first-page":"961","volume":"106","author":"Newcomer LM","year":"2003","journal-title":"Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer"},{"key":"CIT0088","first-page":"844","volume":"105","author":"Dumeaux V","year":"2003","journal-title":"Lund E. Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study. Int J Cancer"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.bjc.6600691","volume":"88","author":"Althuis MD","year":"2003","journal-title":"Br J Cancer"},{"key":"CIT0090","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","journal-title":"Lancet"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.4.485"},{"key":"CIT0093","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"Ross RK","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"CIT0094","first-page":"734","volume":"287","author":"Chen CL","year":"2002","journal-title":"Hormone replacement therapy in relation to breast cancer. J Am Med Assoc"},{"key":"CIT0096","first-page":"321","volume":"288","author":"Rossouw JE","year":"2002","journal-title":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc"},{"key":"CIT0097","first-page":"419","volume":"362","author":"Beral V","year":"2003","journal-title":"Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet"},{"key":"CIT0098","first-page":"1701","volume":"291","author":"Anderson GL","year":"2004","journal-title":"et al., Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc"},{"key":"CIT0099","first-page":"36","volume":"15","author":"Kelsey JL","year":"1993","journal-title":"Reproductive factors and breast cancer. Epidemiol Rev"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-200310010-00003"},{"key":"CIT0103","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00042192-200310020-00003","volume":"10","author":"Position Statement","year":"2003","journal-title":"Menopause"},{"key":"CIT0104","first-page":"61","volume":"29","author":"Schindler AE","year":"1998","journal-title":"Thijssen JR. Aspects of progestin activity on the breast: European Progestin Club. Maturitas"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T"},{"key":"CIT0108","first-page":"278","volume":"79","author":"Bonnier P","year":"1998","journal-title":"Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer. hit J Cancer"},{"key":"CIT0109","first-page":"3115","volume":"16","author":"Holli K","year":"1998","journal-title":"Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Chin Oncol"},{"key":"CIT0110","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6690543","volume":"80","author":"Jernstrom H","year":"1999","journal-title":"Br J Cancer"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706193362501"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1528"},{"key":"CIT0114","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jnci\/88.10.643","volume":"88","author":"Laya MB","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"CIT0115","first-page":"262","volume":"130","author":"Greendale GA","year":"1999","journal-title":"Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med"},{"key":"CIT0117","first-page":"3243","volume":"289","author":"Chlebowski RT","year":"2003","journal-title":"et al., WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. J Am Med Assoc"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O"},{"key":"CIT0119","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1345\/aph.1D462","volume":"38","author":"Swegle JM","year":"2004","journal-title":"Ann Pharmacother"},{"key":"CIT0121","first-page":"463","volume":"69","author":"Kandouz M","year":"1999","journal-title":"Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol"},{"key":"CIT0122","first-page":"422","volume":"9","author":"Cline JM","year":"2002","journal-title":"Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys. Menopause"},{"key":"CIT0123","first-page":"717","volume":"186","author":"Lundstrom E","year":"2002","journal-title":"Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol"},{"key":"CIT0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1677\/erc.0.0110179","volume":"11","author":"Lonning PE","year":"2004","journal-title":"Endocr Rel Cancer"},{"key":"CIT0126","first-page":"27","volume":"67","author":"Burger CW","year":"1996","journal-title":"Kenemans P. LHRH agonist treatment of breast cancer and gynecological malignancies: a review. Eur J Obstet Gynecol Reprod Biol"},{"key":"CIT0127","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.21.1529"},{"issue":"14","key":"CIT0129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0093-7754(03)00304-X","volume":"30","author":"Mauriac L","year":"2003","journal-title":"Semin Oncol"},{"key":"CIT0130","first-page":"4209","volume":"119","author":"Boccardo F","year":"2001","journal-title":"Mustocchi G. Italian Breast Cancer Cooperative Group. Sequential tamoxifen and aminoglutethimide versus tamox-ifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study. J Chin Oncol"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032312"},{"key":"CIT0133","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.bjc.6601508","volume":"90","author":"Wong ZW","year":"2004","journal-title":"Br J Cancer"},{"key":"CIT0134","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","volume":"23","author":"Winer EP","year":"2005","journal-title":"J Chin Oncol"},{"key":"CIT0135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0959-8049(02)00810-9","volume":"39","author":"Robertson JF","year":"2003","journal-title":"Eur J Cancer"},{"key":"CIT0136","first-page":"2556","volume":"13","author":"Hayes DF","year":"1995","journal-title":"J Chin Oncol"},{"key":"CIT0138","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2003.06.108","volume":"21","author":"Buzdar A","year":"2003","journal-title":"J Chin Oncol"},{"key":"CIT0139","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","volume":"19","author":"Goss PE","year":"2001","journal-title":"J Clin Oncol"},{"key":"CIT0141","first-page":"62","volume":"14","author":"Tominaga T","year":"2003","journal-title":"Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer. Ann Oncol"},{"key":"CIT0142","first-page":"2101","volume":"21","author":"Mouridsen H","year":"2003","journal-title":"Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmeno-pausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol"},{"key":"CIT0143","first-page":"2234","volume":"18","author":"Lonning PE","year":"2000","journal-title":"Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibi-tors: a phase II trial. J Clin Oncol"},{"key":"CIT0144","first-page":"4309","volume":"9","author":"Bross PF","year":"2003","journal-title":"Clin Cancer Res"},{"key":"CIT0146","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1998.16.3.994","volume":"16","author":"Taylor CW","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0147","first-page":"343","volume":"19","author":"Klijn JG","year":"2001","journal-title":"Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol"},{"key":"CIT0148","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/1078-0432.CCR-031202","volume":"10","author":"Ellis MJ","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Gynecological Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09513590500128492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T14:50:17Z","timestamp":1553007017000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09513590500128492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":119,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,7,7]]},"published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1080\/09513590500128492"],"URL":"https:\/\/doi.org\/10.1080\/09513590500128492","relation":{},"ISSN":["0951-3590","1473-0766"],"issn-type":[{"value":"0951-3590","type":"print"},{"value":"1473-0766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}